TCL Archive Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer November 28, 2014
TCL Archive In Brief: Shingleton “Unretires” As Director Of Duke Center; O’Brien Interim Head At USC When Hammond Leave July 24, 1981